Ganciclovir for stubborn allergic rhinitis
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether an antiviral medicine called ganciclovir (in capsule form) can help people with stubborn moderate-to-severe allergic rhinitis that doesn't improve with standard treatments. If you have year-round allergies to dust mites and your symptoms are still bothersome, this trial may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have moderate-to-severe year-round allergic rhinitis that is not controlled well by current treatments.
- You are allergic to dust mites or other common indoor allergens like pet dander.
- You are not pregnant, breastfeeding, or planning a pregnancy during the study.
- You do not have a weakened immune system, active infections, or serious health conditions like liver disease or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called washed microbiota transplantation, which transfers gut bacteria from healthy donors to people with allergic rhinitis. The goal is to see if changing the gut bacteria can reduce allergy symptoms like sneezing, itching, and a runny or blocked nose.
This trial tests if arbidol, an antiviral medicine, can safely treat allergic rhinitis (hay fever). It might help if your nasal symptoms like sneezing or stuffiness are moderate to severe.
This study tests an investigational injection (GR1802) that may help reduce seasonal allergy symptoms when standard allergy medications aren't enough. If you qualify, you'll receive the injection during the pollen season to see if it improves your sneezing, runny nose, and itchy eyes.
This early-phase study tests high-concentration ganciclovir eye drops to treat cytomegalovirus (CMV) retinitis, a serious eye infection. It may help people who are hard to treat with regular (systemic) antiviral medicine or who face higher risks with an injection directly into the eye.
This study tests whether a supplement made from yeast beta-glucan can help prevent upper respiratory infections, like colds, in people with persistent allergic rhinitis (year-round nasal allergy symptoms). It may help reduce the number of colds you get.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Hear when a new Rhinitis, Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.